Oral Clinical Nutrition Market Growth & Trends
The global oral clinical nutrition market is expected to reach USD 22,969.4 million by 2030 and expand at a CAGR of 5.0% for the forecast period 2023-2030, according to a new report by Grand View Research, Inc., Oral clinical nutrition are the supplements such electrolytes, protein, fibre, energy, vitamins and minerals essential for the people with nutrient deficiency. This is due to poor appetite, low food intake and illness. These nutritional products are available in the form of powder, liquid, pudding, fiber, dessert, juices, yogurt and so on which can be consumed orally. They also have a wide range of applications in the treatment of chronic diseases such as cancer, neurological conditions and gastrointestinal disorders.
The key market players are involved in the novel product launch contributing to the global market growth. For instance, in April 2018, Abbott launched a beverage Ensure Protein Max with 2 for people over age 50+ having protein deficiency. The beverage contains 30g protein with 150 calories and 9 amino acids and available in two flavors. The beverage is supplemented with 1g sugar and 22 vitamins and minerals such as Vitamin D, C, and E. Such novel product launch by market players is expected to propel market growth.
Dominant market players are also engaged in collaborations, mergers, acquisitions to enhance the product portfolio and improvise the nutrition portfolio of the company and study the clinical nutrition analysis. This has a positive impact on the global market. For instance, in January 2018, Filament BioSolutions, Inc. entered into a strategic collaboration with CHEO, Ottawa and Ottawa University for a project designed to analyze and study the clinical application of microme-based precision nutrition in IBD. The project was funded by CIHR and Genome Canada.
Moreover, there is rising awareness among people regarding a healthy lifestyle, and consumption of a nutritious diet for improving the body's immunity and living a healthy and fit life. Along with this, there is a rising prevalence of chronic diseases such as cancer. According to the research, loss of appetite, and malnutrition is observed due to the side effects of the clinical treatment. Due to this, the researchers are engaged in formulating oral clinical nutrition supplements by enhancing their nutritional value to counter the side effects of the clinical treatment. This helps in the overall growth of the market.
Enquire for customization in Report @https://www.grandviewresearch.com/checkout/select-license/oral-clinical-nutrition-market-report
Oral Clinical Nutrition Market Segmentation
Grand View Research, Inc. has segmented the global oral clinical nutrition market report based on stage, indication, sales channel, and region.
Oral Clinical Nutrition Stage Outlook (Revenue, USD Million, 2018 – 2030)
Oral Clinical Nutrition Indication Outlook (Revenue, USD Million, 2018 – 2030)
- Nutrition Deficiency
- Cancer Care
- Chronic Kidney Diseases
- Orphan Diseases
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
List of Key Players of Oral Clinical Nutrition Market
- Abbott Laboratories
- Pfizer Inc.
- Bayer AG
- Nestle S.A.
- GlaxoSmithKline plc
- Baxter International Inc.
- Otsuka Holdings Co., Ltd.
- Mead Johnson & Company, LLC
- Danone Nutricia
- Victus, Inc.
Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.
Grand View Research
Office No. 705, A Wing, 7th Floor,
Amar Business Zone,
Veerbhadra Nagar, Baner,
Pune, MH, 411045 India
Phone: +91-895-638-0888 (Sales)
Phone: +91-895-638-0891 (HR)